Montelukast thin film (Qilu Pharmaceutical)

N/A

Report date: 2024/05/31 11:59:46

Base Information

Drug NameMontelukast thin film (Qilu Pharmaceutical)
Drug Alias NameMontelukast Sodium Oral Thin Films (Qilu Pharmaceutical)Montelukast Sodium Oral Thin Film (Qilu Pharmaceutical)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCysteinyl leukotriene receptor 1 antagonists
TargetsCysteinyl leukotriene receptor 1
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesQilu Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesQilu Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A